Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

listen audio

Study Justification:
This study aimed to estimate the prevalence of pre-existing multimorbidity (two or more long-term physical or mental health conditions) in pregnant women in the United Kingdom. The justification for this study is based on the fact that although maternal death is rare in the UK, 90% of these women had multiple health/social problems. Understanding the prevalence of multimorbidity in pregnant women is important for identifying potential risks and developing appropriate interventions.
Study Highlights:
– The prevalence of pre-existing multimorbidity in pregnant women in the UK was estimated to be 44.2% in the Clinical Practice Research Datalink (CPRD), 46.2% in the Secure Anonymized Information Linkage databank (SAIL), and 19.8% in the Scottish Morbidity Records (SMR).
– Mental health conditions were highly prevalent, with 70% of women with multimorbidity in the CPRD dataset having at least one mental health condition.
– Logistic regression analysis showed that pregnant women with multimorbidity were more likely to be older, multigravid, have a higher body mass index, and have smoked preconception.
– Secondary care and community prescribing datasets may only capture the severe spectrum of health conditions, indicating the need for further research to understand the consequences of maternal multimorbidity.
Recommendations:
– Further research is needed to quantify the consequences of maternal multimorbidity for both mothers and children.
– Interventions should be developed to mitigate the effect of multimorbidity on adverse pregnancy outcomes.
– Healthcare providers should be aware of the high prevalence of multimorbidity in pregnant women and consider appropriate management strategies.
Key Role Players:
– Researchers and epidemiologists to conduct further research on the consequences of maternal multimorbidity.
– Healthcare providers and clinicians to develop and implement interventions to address the impact of multimorbidity on pregnancy outcomes.
– Policy makers and public health officials to prioritize the management of multimorbidity in pregnant women and allocate resources accordingly.
Cost Items for Planning Recommendations:
– Research funding for further studies on the consequences of maternal multimorbidity.
– Resources for the development and implementation of interventions, including healthcare provider training and patient education.
– Budget for monitoring and evaluation of interventions to assess their effectiveness and make necessary adjustments.
– Allocation of healthcare resources to ensure adequate support and management for pregnant women with multimorbidity.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong, as it is based on a population-based cross-sectional study using routine healthcare datasets from primary care and secondary care in the UK. The study included a large number of pregnant women and provided prevalence estimates of pre-existing multimorbidity. The study also adjusted for various factors using logistic regression analysis. However, to improve the evidence, the abstract could provide more information on the methodology, such as the sampling strategy and data collection process. Additionally, the abstract could mention any limitations of the study, such as potential biases or generalizability issues.

Background: Although maternal death is rare in the United Kingdom, 90% of these women had multiple health/social problems. This study aims to estimate the prevalence of pre-existing multimorbidity (two or more long-term physical or mental health conditions) in pregnant women in the United Kingdom (England, Northern Ireland, Wales and Scotland). Study design: Pregnant women aged 15–49 years with a conception date 1/1/2018 to 31/12/2018 were included in this population-based cross-sectional study, using routine healthcare datasets from primary care: Clinical Practice Research Datalink (CPRD, United Kingdom, n = 37,641) and Secure Anonymized Information Linkage databank (SAIL, Wales, n = 27,782), and secondary care: Scottish Morbidity Records with linked community prescribing data (SMR, Tayside and Fife, n = 6099). Pre-existing multimorbidity preconception was defined from 79 long-term health conditions prioritised through a workshop with patient representatives and clinicians. Results: The prevalence of multimorbidity was 44.2% (95% CI 43.7–44.7%), 46.2% (45.6–46.8%) and 19.8% (18.8–20.8%) in CPRD, SAIL and SMR respectively. When limited to health conditions that were active in the year before pregnancy, the prevalence of multimorbidity was still high (24.2% [23.8–24.6%], 23.5% [23.0–24.0%] and 17.0% [16.0 to 17.9%] in the respective datasets). Mental health conditions were highly prevalent and involved 70% of multimorbidity CPRD: multimorbidity with ≥one mental health condition/s 31.3% [30.8–31.8%]). After adjusting for age, ethnicity, gravidity, index of multiple deprivation, body mass index and smoking, logistic regression showed that pregnant women with multimorbidity were more likely to be older (CPRD England, adjusted OR 1.81 [95% CI 1.04–3.17] 45–49 years vs 15–19 years), multigravid (1.68 [1.50–1.89] gravidity ≥ five vs one), have raised body mass index (1.59 [1.44–1.76], body mass index 30+ vs body mass index 18.5–24.9) and smoked preconception (1.61 [1.46–1.77) vs non-smoker). Conclusion: Multimorbidity is prevalent in pregnant women in the United Kingdom, they are more likely to be older, multigravid, have raised body mass index and smoked preconception. Secondary care and community prescribing dataset may only capture the severe spectrum of health conditions. Research is needed urgently to quantify the consequences of maternal multimorbidity for both mothers and children.

This was a cross sectional analysis of the prevalence of pre-existing multimorbidity prior to the start of pregnancy in the UK across three separate databases. We included index pregnancies where the conception date was between 1/1/2018 and 31/12/2018. Women aged 15–49 years with a conception date in 2018 were eligible. Last menstrual period or gestational day 0 was considered the conception date [5]. When a woman had more than one pregnancy episode in 2018, the first recorded pregnancy in that year was included (not necessarily the first ever pregnancy). Women whose data did not meet standard quality checks were excluded (Additional file 1). This study used three datasets from different health settings, covering all four nations in the UK: Clinical Practice Research Datalink, (CPRD, England, Northern Ireland, Scotland and Wales), Secure Anonymized Information Linkage (SAIL, Wales) and Scottish Morbidity Records (SMR, Scotland). CPRD GOLD contains anonymized, longitudinal medical records for over 19 million patients in the UK (England, Northern Ireland, Scotland and Wales) from over 940 participating general practices; it currently covers 4% of UK GP practices and is widely acknowledged to be representative of the UK population [6]. It includes data on demographics, diagnoses and prescriptions [6]. Linkage to area based deprivation index was available for patients in England. Within CPRD GOLD, the CPRD Pregnancy Register is an algorithm that takes information from maternity, antenatal and delivery health records to detect pregnancy episodes and their outcomes [5]. The SAIL databank is a whole population level database in Wales. It is a repository of anonymized health and socio-economic administrative data and provides linkage at an individual level [7]. It holds data for 4.8 million people and covers 80% of Welsh GP practices [7]. Within SAIL, the National Community Child Health Dataset was used to detect pregnancies and was linked to the Welsh Longitudinal General Practice dataset and the Welsh Demographic Service dataset for diagnoses, prescriptions and demographics data respectively. SMR data was available from two Scottish regional health boards: National Health Service (NHS) Tayside and NHS Fife [8]. A dataset was created linking the Scottish Maternity Records (SMR02) to data from Hospital Admissions (SMR01), Mental Health Inpatients (SMR04), Accident and Emergency, and the Demography and Death registry. This covered diagnoses and demographic data for all inpatient stays and day cases for residents in the two regions. The dataset was also linked to the Prescribing Information System for data on all medications dispensed in the community. Pregnancies were detected from maternity records or pregnancy-related hospital admissions. Multimorbidity was defined by the presence of two or more pre-existing long-term physical or mental health conditions prior to the index pregnancy. We defined long-term conditions as conditions that have ongoing significant impact on patients, including conditions that are relapsing and remitting in nature. One of the wider research aims is to mitigate the effect of multimorbidity on adverse pregnancy outcomes. As pregnancy related conditions (e.g., gestational diabetes and pregnancy induced hypertension) will be subsequently studied as maternal outcomes, they were not included in the definition of pre-existing multimorbidity. An exhaustive list of long-term health conditions was first identified from existing literature [4, 9, 10], in particular based on the work commissioned by Health Data Research UK on multimorbidity conceptualization [10] and health conditions that were leading indirect cause of death in the UK maternal mortality report (MBRRACE) [4]. This list and phenome definitions were refined and harmonized through workshops with our research advisory group, consisting of patient and public representatives, clinicians from general practice, obstetrics, maternal medicine, psychiatry, public health, and data scientists. Seventy nine health conditions were selected on the following basis: (i) prevalence; (ii) potential to impact on pregnancy outcomes; (iii) considered important by women; and (iv) recorded in the study datasets. Diagnoses of these 79 long-term health conditions were determined from Read Codes version 2 (primary care datasets) and the International Classification of Disease 10th version (secondary care datasets) [11]. The validity of diagnostic coding has previously been shown to be good in primary care records and generally health conditions under payment for performance schemes, such as Quality Outcomes Framework, are well coded [12]. Code lists and phenome definitions used are available in Additional files 2 and 3. The primary analysis was the prevalence of pre-existing multimorbidity in pregnant women. The denominator was the total number of index pregnancies identified in 2018, regardless of the pregnancy outcome. Additional analysis was performed for multimorbidity with at least one mental health conditions and active multimorbidity. Active multimorbidity limits common transient/episodic conditions (e.g., mental health, dermatological and atopic conditions and headaches) to those that were active in the 12 months preceding index pregnancy (Additional file 3). Multivariable logistic regression was performed to examine the association of multimorbidity with maternal age (five-yearly categories), ethnicity, deprivation quintiles (patient level Index of Multiple Deprivation [IMD] for all three datasets), latest maternal pre-pregnancy body mass index (BMI) categories, latest pre-pregnancy smoking status, and gravidity (total number of pregnancies up to and including index pregnancy). Obesity was considered a covariate (BMI categories) instead of a health condition. For CPRD, practice level IMD was available for all four nations, but patient level IMD was only available for England, therefore, the regression analysis was limited to England. We then described the prevalence of individual health conditions, and the prevalence of mutually exclusive multimorbidity combinations. Missing data were assigned to separate categories and included in the analyses. Sensitivity analysis was performed for CPRD (England), where missing ethnicity was imputed with data from linked hospital administrative data, and missing patient level IMD was imputed with practice level IMD. Study results were presented for each dataset separately. Data were not combined as there was a possibility of patient overlap between CPRD (Wales, Scotland) with both SAIL (Wales) and SMR (Scotland). Deduplication was not possible as the datasets are anonymized, and only aggregated data were exported within the permission of the data access approval. As our study found no association of recorded multimorbidity with social deprivation, we conducted a post hoc analysis in the CPRD cohort, with the list of conditions used to define multimorbidity in a seminal paper that found this association [13]. We also examined the association of selected health conditions with deprivation and ethnicity. Guided by our patient representatives, we analysed the prevalence of multimorbidity for selected health conditions to illustrate the burden of multimorbidity. The selected health conditions were: i) the top ten most common individual health conditions in this study, and ii) leading causes of maternal deaths [4]. Analysis was performed using STATA 16 and R. The study is reported in accordance with the RECORD guideline (Additional file 4).

Based on the provided description, here are some potential innovations that could improve access to maternal health:

1. Telemedicine and Remote Monitoring: Implementing telemedicine and remote monitoring technologies can allow pregnant women to receive prenatal care and consultations from the comfort of their own homes. This can be especially beneficial for women in rural or underserved areas who may have limited access to healthcare facilities.

2. Mobile Health Applications: Developing mobile health applications specifically designed for maternal health can provide pregnant women with valuable information, resources, and tools to monitor their health and track their pregnancy progress. These apps can also offer personalized recommendations and reminders for prenatal appointments and medication adherence.

3. Community Health Workers: Training and deploying community health workers who can provide education, support, and basic healthcare services to pregnant women in their local communities can help improve access to maternal health. These workers can bridge the gap between healthcare facilities and remote areas, ensuring that women receive the necessary care and guidance throughout their pregnancy.

4. Integrated Health Information Systems: Implementing integrated health information systems that connect primary care providers, hospitals, and other healthcare facilities can improve coordination and continuity of care for pregnant women. This can help ensure that relevant medical information is easily accessible and shared among healthcare providers, leading to better management of pre-existing health conditions and improved maternal outcomes.

5. Targeted Health Education Campaigns: Developing targeted health education campaigns that focus on raising awareness about pre-existing multimorbidity in pregnant women can help reduce stigma and increase understanding among healthcare providers and the general public. These campaigns can emphasize the importance of early detection, appropriate management, and support for pregnant women with multiple health conditions.

6. Collaborative Care Models: Implementing collaborative care models that involve multidisciplinary teams of healthcare professionals, including obstetricians, primary care physicians, mental health specialists, and social workers, can ensure comprehensive and holistic care for pregnant women with pre-existing multimorbidity. This approach can improve care coordination, enhance communication among providers, and address the complex needs of these women.

7. Policy and Funding Support: Advocating for policy changes and increased funding to prioritize maternal health and address the specific needs of pregnant women with pre-existing multimorbidity can help improve access to care. This can include initiatives such as expanding insurance coverage, increasing reimbursement rates for healthcare providers, and investing in research and innovation in the field of maternal health.

It’s important to note that these recommendations are based on the general information provided and may need to be tailored to specific contexts and healthcare systems.
AI Innovations Description
The recommendation that can be developed into an innovation to improve access to maternal health based on the described study is to implement targeted interventions and support programs for pregnant women with pre-existing multimorbidity. These interventions should focus on addressing the specific health needs and challenges faced by this population, such as older age, higher gravidity, raised body mass index, and smoking.

The innovation could involve the following strategies:

1. Integrated care: Develop a coordinated and integrated approach to healthcare delivery for pregnant women with pre-existing multimorbidity. This could involve collaboration between primary care providers, specialists, and other healthcare professionals to ensure comprehensive and holistic care.

2. Personalized care plans: Create individualized care plans for pregnant women with pre-existing multimorbidity, taking into account their specific health conditions, needs, and preferences. This could involve regular monitoring, targeted interventions, and support services tailored to each woman’s unique circumstances.

3. Health education and counseling: Provide comprehensive health education and counseling to pregnant women with pre-existing multimorbidity, focusing on self-management strategies, healthy lifestyle choices, and adherence to treatment plans. This could help empower women to take an active role in their own healthcare and improve their overall health outcomes.

4. Accessible and inclusive healthcare services: Ensure that healthcare services are accessible, inclusive, and culturally sensitive for pregnant women with pre-existing multimorbidity. This could involve removing barriers to healthcare access, providing language interpretation services, and addressing cultural and social determinants of health.

5. Collaboration and partnerships: Foster collaboration and partnerships between healthcare providers, community organizations, and relevant stakeholders to improve access to maternal health services for women with pre-existing multimorbidity. This could involve sharing resources, expertise, and best practices to enhance the quality and effectiveness of care.

By implementing these recommendations, it is possible to improve access to maternal health for pregnant women with pre-existing multimorbidity, ultimately leading to better health outcomes for both mothers and children.
AI Innovations Methodology
Based on the provided description, the study aims to estimate the prevalence of pre-existing multimorbidity in pregnant women in the United Kingdom (UK) and identify associated factors. The study used three datasets from different health settings: Clinical Practice Research Datalink (CPRD), Secure Anonymized Information Linkage (SAIL), and Scottish Morbidity Records (SMR). The prevalence of multimorbidity was determined based on the presence of two or more long-term physical or mental health conditions prior to the index pregnancy.

To improve access to maternal health, the following innovations could be considered:

1. Telemedicine and Remote Monitoring: Implementing telemedicine and remote monitoring technologies can provide pregnant women with access to healthcare services from the comfort of their homes. This can be particularly beneficial for women with pre-existing multimorbidity who may have difficulty traveling to healthcare facilities.

2. Mobile Health Applications: Developing mobile health applications that provide educational resources, appointment reminders, and personalized health information can empower pregnant women to actively manage their health. These applications can also facilitate communication between healthcare providers and patients, ensuring timely access to care.

3. Community Health Workers: Deploying trained community health workers who can provide support, education, and guidance to pregnant women with pre-existing multimorbidity can improve access to maternal health services. These workers can bridge the gap between healthcare facilities and communities, ensuring that women receive the necessary care and support.

4. Integrated Care Models: Implementing integrated care models that bring together different healthcare providers and services can improve coordination and continuity of care for pregnant women with pre-existing multimorbidity. This approach ensures that women receive comprehensive and holistic care, addressing both their physical and mental health needs.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could involve the following steps:

1. Define Key Metrics: Identify key metrics that reflect access to maternal health, such as the number of prenatal visits, timely access to specialized care, and patient satisfaction.

2. Baseline Data Collection: Collect baseline data on the identified metrics before implementing the recommendations. This can be done through surveys, interviews, or analysis of existing healthcare data.

3. Implement Innovations: Implement the recommended innovations, such as telemedicine, mobile health applications, community health worker programs, or integrated care models.

4. Data Collection Post-Implementation: Collect data on the identified metrics after implementing the innovations. This can be done through follow-up surveys, interviews, or analysis of healthcare data.

5. Compare Pre- and Post-Implementation Data: Analyze the data collected before and after implementing the innovations to assess the impact on access to maternal health. Compare the key metrics to determine if there have been improvements.

6. Statistical Analysis: Use statistical analysis techniques to determine the significance of any observed changes and assess the effectiveness of the innovations in improving access to maternal health.

7. Iterative Improvement: Based on the findings, refine and iterate the innovations to further enhance access to maternal health.

By following this methodology, it is possible to simulate the impact of the recommended innovations on improving access to maternal health for pregnant women with pre-existing multimorbidity.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email